The durability of infection-induced SARS-CoV-2 immunity has major implications for reinfection
and vaccine development. Here, we show a comprehensive profile of antibody, B cell …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has
dramatically expedited global vaccine development efforts 1 , 2 – 3 , most targeting the viral ‘spike’ …

Macrophages are key cellular contributors to the pathogenesis of COVID-19, the disease
caused by the virus SARS-CoV-2. The SARS-CoV-2 entry receptor ACE2 is present only on a …

To better understand primary and recall T cell responses during coronavirus disease 2019 (COVID-19),
it is important to examine unmanipulated severe acute respiratory syndrome …

SARS-CoV-2 causes a spectrum of COVID-19 disease, the immunological basis of which
remains ill defined. We analyzed 85 SARS-CoV-2-infected individuals at acute and/or …

Neutralizing antibodies are important for immunity against SARS-CoV-2 and as therapeutics
for the prevention and treatment of COVID-19. Here, we identified high-affinity nanobodies …

Background Given the scale of the ongoing COVID-19 pandemic, the development of vaccines
based on different platforms is essential, particularly in light of emerging viral variants, the …

Importance The immune response in children with SARS-CoV-2 infection is not well understood.
Objective To compare seroconversion in nonhospitalized children and adults with mild …

Compared to adults, children with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
have predominantly mild or asymptomatic infections, but the underlying …

SARS-CoV-2 vaccines are advancing into human clinical trials, with emphasis on eliciting
high titres of neutralising antibodies against the viral spike (S). However, the merits of broadly …